The stock of DocGo Inc (DCGO) has gone down by -8.57% for the week, with a -39.34% drop in the past month and a -74.55% drop in the past quarter. The volatility ratio for the week is 6.31%, and the volatility levels for the past 30 days are 7.53% for DCGO. The simple moving average for the last 20 days is -32.41% for DCGO stock, with a simple moving average of -63.60% for the last 200 days.
Is It Worth Investing in DocGo Inc (NASDAQ: DCGO) Right Now?
The 36-month beta value for DCGO is at 0.92. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for DCGO is 85.91M, and currently, shorts hold a 7.58% of that float. The average trading volume for DCGO on May 22, 2025 was 1.21M shares.
DCGO) stock’s latest price update
DocGo Inc (NASDAQ: DCGO) has seen a decline in its stock price by -7.91 in relation to its previous close of 1.39. However, the company has experienced a -8.57% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-19 that NEW YORK–(BUSINESS WIRE)–DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo’s brea.
Analysts’ Opinion of DCGO
Deutsche Bank, on the other hand, stated in their research note that they expect to see DCGO reach a price target of $2.85, previously predicting the price at $5. The rating they have provided for DCGO stocks is “Hold” according to the report published on February 28th, 2025.
BTIG Research gave a rating of “Buy” to DCGO, setting the target price at $15 in the report published on August 18th of the previous year.
DCGO Trading at -44.43% from the 50-Day Moving Average
After a stumble in the market that brought DCGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.44% of loss for the given period.
Volatility was left at 7.53%, however, over the last 30 days, the volatility rate increased by 6.31%, as shares sank -40.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.45% lower at present.
During the last 5 trading sessions, DCGO fell by -8.57%, which changed the moving average for the period of 200-days by -60.62% in comparison to the 20-day moving average, which settled at $1.8937. In addition, DocGo Inc saw -69.81% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DCGO starting from Burdiek Michael J, who purchase 15,000 shares at the price of $1.43 back on May 15 ’25. After this action, Burdiek Michael J now owns 631,560 shares of DocGo Inc, valued at $21,450 using the latest closing price.
Klasko Stephen K. M.D., the Director of DocGo Inc, purchase 15,000 shares at $1.49 during a trade that took place back on May 14 ’25, which means that Klasko Stephen K. M.D. is holding 15,000 shares at $22,350 based on the most recent closing price.
Stock Fundamentals for DCGO
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.33 for the gross margin
The net margin for DocGo Inc stands at -0.0. The total capital return value is set at -0.0. Equity return is now at value -0.21, with -0.14 for asset returns.
Based on DocGo Inc (DCGO), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at 1.49. The debt to equity ratio resting at 0.2. The interest coverage ratio of the stock is -0.8.
Currently, EBITDA for the company is 45.8 million with net debt to EBITDA at -1.18. When we switch over and look at the enterprise to sales, we see a ratio of 0.21. The receivables turnover for the company is 2.91for trailing twelve months and the total asset turnover is 1.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.44.
Conclusion
In conclusion, DocGo Inc (DCGO) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
